Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary

Update Il y a 4 ans
Reference: NCT02590055

Woman and Man

Extract

It's a phase 2, single arm study of gemcitabine an docetaxel combination in patients with carcinoma of unknown primary.


Inclusion criteria

  • Carcinoma of Unknown Primary

Links